Diagonal Therapeutics’ innovative clustering antibodies for vascular diseases
Dylan Kissane
Today we’re joined by Patrick Andre, Chief Scientific Officer at Diagonal Therapeutics. In this episode, Patrick walks us through the company’s DIAGONAL platform, and its lead program DIAG723 The post Diagonal Therapeutics’ innovative clustering antibodies for vascular diseases appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. E